Is a complete IST/BIOEN research report available?

No complete published report is available for ist/BIOEN (IST/BIOEN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

IST/BIOEN (IST/BIOEN)

Istanbul Stock Exchange: IST/BIOEN · TRY

TRY 17.2

-0.40 (-2.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IST/BIOEN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8.8B
Revenue (ttm)	2.8B
Net income (ttm)	-860.8M
EPS (ttm)	-TRY 1.72
Shares out	500M
Volume	7,428,547
Beta	0.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.8B
Net income (ttm): -860.8M
EPS (ttm): -TRY 1.72
Market cap: 8.8B

All IST/BIOEN indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

TRY

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	818
Employees Change	-6%
Employees Change Percent	-0.73
Enterprise value	TRY 14.5B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Utilities - Renewable
Isin	TREBION00012
Last refreshed	2026-07-31
Market cap	TRY 8.8B
Price	TRY 17.2
Price currency	TRY
Rev Per Employee	3,457,156.36x
Sector	Utilities
Sector PE Fwd	16.16
Sic	4911
Symbol	ist/BIOEN
Website	https://www.biotrendenerji.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.78%
EV/EBITDA	165.22x
EV/Sales	5.14x
FCF yield	-0.7%
P/B ratio	2.69x
P/S ratio	3.11x
PE Ratio5 Y	101.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-25.53%
EBITDA Margin	3.11%
Gross margin	-2.58%
Gross Profit	TRY -73M
Net Income	TRY -860.8M
Pretax Margin	-20.1%
Profit Margin	-30.44%
Profit Per Employee	TRY -1.1M
ROA	-4.48
Roa5y	1.06
ROCE	-8.6
ROE	-23.33
Roe5y	8.12
ROIC	-5.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.48%
Cagr3y	-3.11%
Cagr5y	16.07%
OCF Growth3 Y	-38.48%
OCF Growth5 Y	62.07%
Revenue Growth	-19.61x
Revenue Growth Q	-13.67x
Revenue Growth3 Y	0.92x
Revenue Growth5 Y	60.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 0.28
Assets	TRY 11B
Cash	TRY 131.6M
Current Assets	TRY 953.2M
Current Liabilities	TRY 2.6B
Debt	TRY 5.9B
Debt EBITDA	TRY 27.7
Debt Equity	TRY 1.79
Debt FCF	TRY -95
Equity	TRY 3.3B
Interest Coverage	-1.25
Liabilities	TRY 7.7B
Long Term Assets	TRY 10B
Long Term Liabilities	TRY 5.1B
Net Cash	TRY -5.7B
Net Cash By Market Cap	TRY -65.16
Net Debt EBITDA	TRY 65.22
Net Debt Equity	TRY 1.75
Tangible Book Value	TRY 2.8B
Tangible Book Value Per Share	TRY 5.69
WACC	5.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.37
Inventory Turnover	9.47
Net Working Capital	TRY 20.6M
Quick ratio	0.17
Working Capital	TRY -1.6B
Working Capital Turnover	TRY -2.32

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.47%
200-day SMA	18.77
3Y total return	-9.04%
50-day SMA	17.68
50-day SMA vs 200-day SMA	50under200
5Y total return	110.63%
All Time High	27.96
All Time High Change	-38.48%
All Time High Date	2025-10-01
All Time Low	4.68
All Time Low Change	267.52%
All Time Low Date	2022-02-24
ATR	0.83
Beta	0.1
Beta1y	0.14
Beta2y	-0.08
Ch YTD	2.99
High	17.62
High52	27.96
High52 Date	2025-10-01
High52ch	-38.48%
Low	17.15
Low52	14.67
Low52 Date	2026-03-02
Low52ch	17.25%
Ma50ch	-2.74%
Price vs 200-day SMA	-8.37%
RSI	46.25
RSI Monthly	47.84
RSI Weekly	45.39
Sharpe ratio	-0.23x
Sortino ratio	-0.24
Tr YTD	2.99
Tr1m	-8.36%
Tr1w	1.3%
Tr3m	-10.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY -721.9M
Operating margin	-25.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	197,934,886%
Net Borrowing	538,310,476
Shares Institutions	14.86%
Shares Out	500,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	13,964,326.75x
Bv Per Share	6.55
CAPEX	TRY -501.5M
Ch1m	-8.36
Ch1w	1.3
Ch1y	-17.47
Ch3m	-10.04
Ch3y	-9.04
Ch5y	110.6
Ch6m	-10.88
Change	-2.27%
Change From Open	-2.27
Close	17.6
Days Gap	0
Dollar Volume	127,771,008.4
Earnings Date	2026-08-14
EBIT	TRY -721.9M
EBITDA	TRY 87.9M
EPS	TRY -1.72
F Score	2
FCF	TRY -61.7M
FCF EV Yield	-0.42x
FCF Per Share	TRY -0.12
Financing CF	66,994,497
Fiscal Year End	December
Founded	2,017
Income Tax	TRY 292.5M
Investing CF	-385,062,997
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2026-03-31
Last Split Date	2021-11-24
Last Split Type	Forward
Ma150	17.89
Ma150ch	-3.84%
Ma20	17.56
Ma20ch	-2.07%
Net CF	56,022,407
Next Earnings Date	2026-08-14
Open	17.6
P OCF Ratio	20.01
Position In Range	10.64
Ppne	7,937,456,405
Price Date	2026-07-30
Price EBITDA	TRY 100
Ptbv Ratio	3.1
Relative Volume	0.53x
Revenue	2,827,953,906x
Tax By Revenue	10.34x
Tr6m	-10.88%
Volume	7,428,547

IST/BIOEN (IST/BIOEN)

Coverage state: Market snapshot only — no published research

Generate the first IST/BIOEN analysis

Price

Financial snapshot

Fair-value bridge

Latest news · IST/BIOEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IST/BIOEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IST/BIOEN

Frequently asked questions